Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.8 USD | -0.73% | -0.37% | +102.99% |
Mar. 28 | Applied Therapeutics Shares Slip 13% After FDA Extends Drug Review | DJ |
Mar. 28 | FDA Extends Review Period for Applied Therapeutics Genetic Disease Treatment | DJ |
Business Summary
Number of employees: 25
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Biopharmaceutical
100.0
%
| 0 | nan % | 10 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | nan % | 10 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 45 | 16-01-19 | |
Les Funtleyder
DFI | Director of Finance/CFO | 55 | 16-05-31 |
Chief Operating Officer | 57 | Dec. 27 | |
Chief Tech/Sci/R&D Officer | 64 | 18-07-31 | |
Catherine Thorpe
AUD | Comptroller/Controller/Auditor | - | 23-06-15 |
Adam Hansard
PRN | Corporate Officer/Principal | 48 | 20-03-02 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jay Skyler
BRD | Director/Board Member | 77 | 19-03-31 |
Joel Marcus
BRD | Director/Board Member | 76 | 16-12-31 |
Teena Lerner
BRD | Director/Board Member | 66 | 17-02-28 |
Stacy J. Kanter
BRD | Director/Board Member | 65 | 19-04-30 |
Les Funtleyder
DFI | Director of Finance/CFO | 55 | 16-05-31 |
Chief Executive Officer | 45 | 16-01-19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 105,886,831 | 98,569,641 ( 93.09 %) | 0 | 93.09 % |
Company contact information
Applied Therapeutics, Inc.
545 5th Avenue Suite 1400
10017, New York
+212 220 9226
http://www.appliedtherapeutics.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+102.99% | 720M | |
+2.73% | 108B | |
+9.59% | 103B | |
+6.58% | 23.48B | |
-12.59% | 21.93B | |
-3.29% | 19.68B | |
-35.36% | 18.37B | |
-13.29% | 16.33B | |
+4.68% | 13.72B | |
+34.25% | 12.15B |
- Stock
- Equities
- Stock Applied Therapeutics, Inc. - Nasdaq
- Company Applied Therapeutics, Inc.